BioNexus Gene Lab Corp. (BGLC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioNexus Gene Lab Corp.

    NASDAQ: BGLC · Real-Time Price · USD
    5.65
    -0.35 (-5.83%)
    At close: Sep 26, 2025, 3:59 PM
    5.73
    1.42%
    After-hours: Sep 26, 2025, 07:23 PM EDT

    BioNexus Gene Lab Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.38M 5.93M 2.12M 2.12M
    Short-Term Investments
    		 n/a 3.31M 1.51M 1.55M
    Long-Term Investments
    		 1.27M 1.7M 1.15M 749.03K
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 1.58M 857.26K 2.9M 3.36M
    Inventory
    		 1.39M 1.14M 977.81K 1.52M
    Other Current Assets
    		 84.17K 122.43K 25.24K 147.12K
    Total Current Assets
    		 7.43M 8.05M 6.02M 7.15M
    Property-Plant & Equipment
    		 1.74M 1.65M 1.57M 1.68M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 3M 3.35M 2.72M 2.42M
    Total Assets
    		 10.43M 11.4M 8.74M 9.57M
    Account Payables
    		 1.5M 1.4M 1.86M 2.01M
    Deferred Revenue
    		 95.88K n/a 23.12K 107.58K
    Short-Term Debt
    		 17.17K 13.2K 16.57K 39.51K
    Other Current Liabilities
    		 284.11K 180.91K 86.8K 71.81K
    Total Current Liabilities
    		 1.95M 1.63M 2M 2.33M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 12.26K 30.87K n/a
    Total Long-Term Liabilities
    		 159.74K 111.02K 71.07K 65.86K
    Total Liabilities
    		 2.11M 1.74M 2.08M 2.39M
    Total Debt
    		 210.56K 133.4K 56.77K 76.95K
    Book Value
    		 8.32M 9.66M 6.67M 7.18M
    Book Value Per Share
    		 4.67 5.61 4.63 5.03
    Common Stock
    		 17.33M 17.19M 10.93M 10.78M
    Retained Earnings
    		 -3.44M -1.84M 1.16M 1.51M
    Comprehensive Income
    		 -555K -677.29K -409.06K -100.26K
    Shareholders Equity
    		 8.32M 9.66M 6.67M 7.18M
    Total Investments
    		 1.27M 1.7M 1.15M 749.03K

    Add to Watchlist